MARGARET GOODELL to Gene Expression Regulation, Leukemic
This is a "connection" page, showing publications MARGARET GOODELL has written about Gene Expression Regulation, Leukemic.
Connection Strength
1.267
-
Mutant NPM1 Maintains the Leukemic State through HOX Expression. Cancer Cell. 2018 09 10; 34(3):499-512.e9.
Score: 0.618
-
Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners. J Biol Chem. 2019 03 29; 294(13):4898-4910.
Score: 0.159
-
New insights into the biology of acute myeloid leukemia with mutated NPM1. Int J Hematol. 2019 Aug; 110(2):150-160.
Score: 0.158
-
DNMT3A in Leukemia. Cold Spring Harb Perspect Med. 2017 Feb 01; 7(2).
Score: 0.138
-
DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia. Blood. 2016 08 18; 128(7):971-81.
Score: 0.133
-
Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes. Exp Hematol. 2016 08; 44(8):740-4.
Score: 0.033
-
A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells. Blood. 2013 Dec 12; 122(25):4086-9.
Score: 0.028